Ikarian Capital, LLC
- SEC CIK
- 0001778253
- 最新申報
- 2026/8/14
2022 年第 4 季持倉
持倉截至 2022/12/31，2023/2/14 申報。只含多頭部位，變化是跟 2022 年第 3 季比股數。
- 持股檔數
- 67
- 較 2022 年第 3 季 +2
- 總值
- $2.41 億
- 較 2022 年第 3 季 +$4,064 萬 (+20.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| RXDXPrometheus Biosciences, Inc. | COM | 288,926 | $3,178 萬 | 13.2% | +57,745+25.0% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 966,700 | $1,716 萬 | 7.1% | +155,000+19.1% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 250,000 | $1,199 萬 | 5.0% | +250,000 | 新進 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 267,476 | $1,192 萬 | 4.9% | −50,000−15.7% | 減碼 | 歷史 |
| ESPREsperion Therapeutics, Inc. | COM | 1,891,147 | $1,178 萬 | 4.9% | −240,000−11.3% | 減碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 837,500 | $1,162 萬 | 4.8% | +837,500 | 新進 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 89,219 | $1,015 萬 | 4.2% | +15,000+20.2% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 675,176 | $1,005 萬 | 4.2% | −24,264−3.5% | 減碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 377,021 | $807.2 萬 | 3.3% | −601,762−61.5% | 減碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 737,319 | $750.6 萬 | 3.1% | −166,800−18.4% | 減碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 885,334 | $727.7 萬 | 3.0% | +35,200+4.1% | 加碼 | – |
| VRNAVerona Pharma plc | SPONSORED ADS | 255,131 | $666.7 萬 | 2.8% | −60,000−19.0% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 160,486 | $632.8 萬 | 2.6% | 00.0% | 不變 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 367,119 | $601.7 萬 | 2.5% | −125,156−25.4% | 減碼 | 歷史 |
| ETNB89bio, Inc. | COM | 454,000 | $577.9 萬 | 2.4% | +254,000+127.0% | 加碼 | 歷史 |
| BLUEbluebird bio, Inc. | COM | 812,628 | $562.3 萬 | 2.3% | +350,000+75.7% | 加碼 | 歷史 |
| BTAIQBioXcel Therapeutics, Inc. | COM | 250,000 | $537.0 萬 | 2.2% | +250,000 | 新進 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 325,000 | $517.4 萬 | 2.1% | 00.0% | 不變 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 108,100 | $489.8 萬 | 2.0% | +108,100 | 新進 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 273,432 | $449.8 萬 | 1.9% | −198,622−42.1% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 629,986 | $443.5 萬 | 1.8% | −98,600−13.5% | 減碼 | 歷史 |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,765,530 | $412.1 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| ARDXArdelyx, Inc. | COM | 1,378,825 | $393.0 萬 | 1.6% | −1,800,000−56.6% | 減碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 127,921 | $374.8 萬 | 1.6% | −72,079−36.0% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 28,324 | $367.0 萬 | 1.5% | +11,515+68.5% | 加碼 | 歷史 |
| SGENSeagen Inc. | COM | 25,000 | $321.3 萬 | 1.3% | +25,000 | 新進 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 137,987 | $285.4 萬 | 1.2% | +137,987 | 新進 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 67,805 | $258.6 萬 | 1.1% | −90,000−57.0% | 減碼 | 歷史 |
| MRUSMerus N.V. | COM | 156,000 | $241.3 萬 | 1.0% | +156,000 | 新進 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 203,156 | $191.0 萬 | 0.8% | −260,000−56.1% | 減碼 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 460,416 | $182.3 萬 | 0.8% | −395,200−46.2% | 減碼 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 422,625 | $156.4 萬 | 0.6% | +422,625 | 新進 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 254,945 | $137.7 萬 | 0.6% | −95,055−27.2% | 減碼 | 歷史 |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 46,462 | $131.2 萬 | 0.5% | −50,000−51.8% | 減碼 | – |
| LYRALyra Therapeutics, Inc. | COM | 343,685 | $107.9 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 85,200 | $105.4 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 139,565 | $101.7 萬 | 0.4% | −310,841−69.0% | 減碼 | 歷史 |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 313,392 | $100.3 萬 | 0.4% | +67,496+27.4% | 加碼 | 歷史 |
| IMUXImmunic, Inc. | COM | 650,000 | $91.0 萬 | 0.4% | +650,000 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 62,766 | $72.6 萬 | 0.3% | −100,000−61.4% | 減碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 200,000 | $56.2 萬 | 0.2% | −65,000−24.5% | 減碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 221,830 | $51.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 188,664 | $50.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 260,087 | $49.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMTXImmatics N.V. | SHS | 49,031 | $42.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 156,203 | $37.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM | 155,819 | $36.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 150,000 | $35.7 萬 | 0.1% | +150,000 | 新進 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 349,133 | $34.7 萬 | 0.1% | −219,479−38.6% | 減碼 | 歷史 |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 448,101 | $32.3 萬 | 0.1% | 00.0% | 不變 | – |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 189,935 | $31.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 30,286 | $28.0 萬 | 0.1% | −138,337−82.0% | 減碼 | 歷史 |
| BIIBBiogen Inc. | COM | 962 | $26.6 萬 | 0.1% | −10,000−91.2% | 減碼 | 歷史 |
| SYBXSynlogic, Inc. | COM | 306,757 | $23.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 65,491 | $22.9 萬 | 0.1% | +65,491 | 新進 | 歷史 |
| CNTBConnect Biopharma Holdings Ltd | ADS | 219,501 | $19.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 820,455 | $15.1 萬 | 0.1% | 00.0% | 不變 | – |
| ARK Innovation ETF00214Q104 | ETF | 4,519 | $14.1 萬 | 0.1% | 00.0% | 不變 | – |
| STSASatsuma Pharmaceuticals, Inc. | COM | 136,059 | $12.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 11,568 | $11.9 萬 | <0.1% | +11,568 | 新進 | 歷史 |
| FNCHFinch Therapeutics Group, Inc. | COM | 237,553 | $11.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SPPISpectrum Pharmaceuticals Inc | COM | 176,980 | $6.52 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM | 397,168 | $4.39 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 75 | $2.18 萬 | <0.1% | +75 | 新進 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 6,100 | $1.32 萬 | <0.1% | −604,307−99.0% | 減碼 | 歷史 |
| Erytech Pharma29604W108 | SPONSORED ADR | 3,019 | $1,185 | <0.1% | 00.0% | 不變 | – |
| KDNYChinook Therapeutics, Inc. | COM | 283,464 | $0 | 0.0% | 00.0% | 不變 | 歷史 |
選擇權（16 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| MDGLMadrigal Pharmaceuticals, Inc. | COM | $8,708 萬 | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $830.0 萬 | $830.0 萬 |
| KRYSKrystal Biotech, Inc. | COM | $1,314 萬 | – |
| RXDXPrometheus Biosciences, Inc. | COM | – | $1,100 萬 |
| ALTAltimmune, Inc. | COM NEW | – | $949.8 萬 |
| ESPREsperion Therapeutics, Inc. | COM | – | $808.0 萬 |
| RETAReata Pharmaceuticals Inc | CL A | $764.4 萬 | – |
| RCUSArcus Biosciences, Inc. | COM | $585.5 萬 | – |
| VRNAVerona Pharma plc | SPONSORED ADS | – | $522.6 萬 |
| ARVNArvinas, Inc. | COM | – | $342.1 萬 |
| ATXSAstria Therapeutics, Inc. | COM | – | $254.8 萬 |
| GERNGeron Corp | COM | $36.3 萬 | $157.3 萬 |
| DSGNDesign Therapeutics, Inc. | COM | $49.8 萬 | $8,208 |
| BIIBBiogen Inc. | COM | – | $49.8 萬 |
| IMVTImmunovant, Inc. | COM | – | $46.5 萬 |
| TCDATricida, Inc. | COM | – | $2.23 萬 |
2022 年第 3 季之後清倉（11 檔）
2022 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 3 季股數 | 2022 年第 3 季市值 | 2022 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CERECerevel Therapeutics Holdings, Inc. | COM | 178,100 | $503.3 萬 | 2.5% | 歷史 |
| SCPHscPharmaceuticals Inc. | COM | 479,383 | $312.6 萬 | 1.6% | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 100,000 | $270.0 萬 | 1.3% | 歷史 |
| CINCCinCor Pharma, Inc. | COM | 45,100 | $148.1 萬 | 0.7% | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 131,310 | $84.3 萬 | 0.4% | 歷史 |
| RCORRenovacor, Inc. | COM | 288,119 | $72.5 萬 | 0.4% | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 2,800 | $56.0 萬 | 0.3% | 歷史 |
| CLVSClovis Oncology, Inc. | COM | 361,518 | $43.0 萬 | 0.2% | 歷史 |
| Stealth Biotherapeutics Corp85789A105 | SPONSORED ADS | 435,516 | $13.4 萬 | 0.1% | – |
| RETAReata Pharmaceuticals Inc | CL A | 4,064 | $10.2 萬 | 0.1% | 歷史 |
| IVAInventiva S.A. | ADS | 13,236 | $4.80 萬 | <0.1% | 歷史 |